debt cap
valu usd unless otherwis note
organ growth end high note
view good finish gallagh strong
organ growth across brokerag unit expect top-lin
momentum continu expect modest margin
expans year environ remain competit
although gallagh get share deal remain sector perform
share current valuat
estimates/pric target revis ep forecast
new estim incorpor
benefit tax reform brokerag risk manag unit
along slightli higher organ growth assumpt bump
price target approxim
ep ebitda/shar estim previou multipl
incorpor tax reform ep ebitda/shar
summari report adjust ep
vs top estim consensu
better-than-expect ep contribut corpor segment
respons upsid remain
upsid brokerag due higher-than-anticip organ growth
brokerag risk manag organ growth outpac
expect organ growth brokerag segment strengthen
vs averag first three quarter beat
expect manag guid temper growth
segment due time issu manag guid
organ growth similar possibl bit better rel
level segment
margin bit soft even strong organ growth brokerag
unit adjust ebitdac margin rose basi point
estim albeit line manag forecast
expect much way margin expans quarter disrupt
mexican oper technolog project weigh brokerag
margin basi point risk manag adjust ebitdac margin
declin basi point estim
posit strong organ growth brokerag segment particularli
intern employe benefit economi price
posit influenc top line tax reform net
posit compani
neg risk manag margin weaken y/i basi
 environ remain competit multipl paid rise
compani see expens pressur cite organ
growth need see margin expans
price prior trade day market close estimate unless otherwis note
arthur gallagh continu experi solid organ
growth busi brokerag unit perform
well economi start improv price outlook
bit brighter risk manag continu gener
good growth expect continu despit
solid organ growth expect expect limit
margin expans anticip compani
activ program focu small bolt-on deal
rather larger-s deal compani also big
opportun grow intern year ahead
acquisit organ gallagh name
gain traction outsid sector perform
rate reflect view share fairli valu
current multipl given subdu margin outlook
 remain part stori deal environ
remain competit due privat equiti involv
expect compani still manag find suitabl
acquisit opportun next year
solid organ growth new busi gener
domest insur busi core middle-market
custom continu good risk manag
unit start show improv top-lin trend
pay-out ratio yield remain fairli appeal provid
downsid protect stock
upside/risk invest thesi
integr recent acquisit although compani
announc new big deal recent
still integr risk associ particularli
margins/expens control despit compani
better job manag cost recent year think
improv margin difficult current level
without signific revenu gain given rise cost
environ broker
program present uncertainti ep pictur
leav compani subject chang coal price ir
tax treatment synfuel credit lower visibl
profit invest
bloomberg capit market estim upside/downside/target
base case incorpor adjust oper ep
estim assum brokerag commiss
fee growth roughli top-lin forecast assum
good contribut slight price increas
solid organ growth trend unit assum
adjust ebitdac margin factor
modest margin expans reason margin recent
acquisit posit impact tax reform
price target approxim ep
upsid scenario assum commiss fee
growth could driven better-than-
 solid intern growth scenario
factor addit basi point margin improv
result good cost contain better-than-
anticip oper leverag revenu gain upsid
scenario incorpor multipl ep
adjust ebitdac forecast
downsid scenario assum commiss fee
growth reflect challeng econom
new busi environ flat insur price
assum basi point margin contract rel
expect result higher-than-expect cost
weaker margin recent acquisit less favor
oper leverag lower rel sale gain downsid
scenario assum multipl approxim
ep adjust ebitdac forecast
takeaway quarter
robust organ growth quarter although margin didnt get lift brokerag
unit produc one highest organ growth quarter year strength
across board growth continu posit stori
particularli strong growth australia/new zealand employe benefit also
nice quarter organ growth uptick recent pace
economi also start bigger increment benefit insur price
improv slightli price flat slightli higher manag guid organ
growth brokerag unit run close slightli better pace
think highli achiev economi price turn right direct
brokerag ebitdac margin soft basi point y/i although
combin basi point impact mexican earthquak mexican oper
well technolog project forecast brokerag ebitdac margin improv
basi point expens growth limit margin expans
risk manag saw modest organ growth margin compress risk
manag organ growth outpac expect big
slow growth rate seen previou two quarter
time advers impact organ growth rate quarter although
amount difficult assess risk manag ebitdac margin disappoint
basi point margin end flat year manag
outlook unit organ growth ebitdac margin similar last year organ
growth around would expect littl better margin outlook
unit although tend think part outlook could slightli
tax rate new revenu recognit standard manag guid tax rate
rang brokerag segment vs report
rang risk manag unit vs record
meaning benefit off-set corpor segment guidanc reflect
unit wont gener level tax credit seen compani didnt
specif quantifi impact fasb revenu recognit principl except
say anticip new principl slight cumul benefit result
brokerag unit given manag believ account methodolog
conserv particularli book conting commiss bill current
estim use gallagh previou revenu recognit polici updat
estim compani provid guidanc revenu recognit standard
next investor meet
competit market gallagh still close deal
mean compani activ year transact mm annual
revenu compani still manag close fair number transact
remain competit market expect stay engag
program estim mm annual revenu acquisit
although deal count may run manag desir due rise
competit deal price manag note multipl paid could rise turn due
passag tax reform even still gallagh sign agre close
sign term sheet acquisit million annual revenu term
sheet indic solid deal pipelin
revis ep forecast
new estim incorpor benefit tax reform brokerag risk
manag unit along slightli higher organ growth assumpt
oper highlight report adjust ep vs
year-ago quarter top estim consensu
expect better-than-expect ep contribut corpor segment
respons upsid remain upsid brokerag due
higher-than-anticip organ growth invest incom gain realiz sale
book busi total million vs million better million
assumpt total integration/restructur charg
nearli brokerag segment
total brokerag commiss fee revenu grew million outpac
million expect brokerag supplement conting commiss total
million vs million ahead million assumpt organ growth
brokerag segment strengthen vs averag first three quarter
beat expect brokerag unit adjust ebitdac margin rose
basi point estim albeit line manag forecast
expect much way margin expans quarter adjust compens
expens ratio rose basi point adjust oper expens ratio fell
basi point manag expect brokerag organ growth run close
perhap even better organ growth rate
risk manag total fee rose million better million
forecast risk manag organ revenu rose better expect
manag guid temper growth segment due time issu risk
manag adjust ebitdac margin declin basi point estim
adjust compens expens ratio fell basi point
adjust oper expens ratio rose basi point manag guid
segment produc organ growth ebitdac margin similar level
corpor segment produc adjust ep vs compar favor
expect dollar term corpor segment adjust earn
million vs million well million estim total corpor segment
revenu rose million manag provid preliminari guidanc
rang adjust loss million profit million corpor
gallagh announc acquisit million revenu close
pace seen throughout gallagh issu share
consider repurchas similar amount share off-set impact
compani also announc two acquisit far
gallagh weight averag ebitdac multipl paid acquisit
rel consist multipl paid throughout past year deal
remain smaller size million annual revenu per properti acquir
fourth quarter
earlier week rais quarterli dividend roughli
consist compani long-stand strategi focu dividend
gallagh cash cash equival increas million million
end like boost modest spend quarter
total debt outstand end year billion roughli sequenti basi
billion end
price target approxim ep ebitdac/shar forecast
price target support sector perform rate stock current trade
ep forecast roughli line peer group rang stock
trade premium peer time think in-lin multipl appropri due
subdu margin expans prospect rel certain peer less credit ep
driven clean coal earn
risk rate price target
believ signific risk price target rate includ continu industri
wide price pressur higher expect employe cost unexpect invest loss
unanticip cost relat recent acquisit
arthur gallagh intern insur brokerag risk manag servic
firm headquart itasca illinoi compani core busi entail provid insur
brokerag risk manag altern risk transfer insur small- medium-
size compani compani oper major market also oper
servic capabl countri compani third-largest insur
broker fourth-largest world
deprec amort expens
deprec amort expens
compani report capit market estim
